..As part of the extensive clinical development programs for modern T2DM therapies, SGLT2 inhibitors have been studied in combination with the most commonly used classes of glucose-lowering medications...

Use of the dipeptidyl peptidase-4 inhibitor linagliptin in combination therapy for type 2 diabetes